Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Eyerich

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2024
IL-6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort studyA Reimer-Taschenbrecker, M Hess, M Davidovic, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 10, 2023
An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasisK Eyerich, J Krueger, M Stahle, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2016
Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donorN Garzorz, J Thomas, B Eberlein, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2020
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019T Luger, T Dirschka, K Eyerich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 2, 2020
Transferability of suggested molecular classifiers for psoriasis and eczema to the Chinese populationM-N Xu, L Li, W Pan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2015
Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseasesN Garzorz, M Alsisi, A Todorova, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 7, 2023
Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2A Armstrong, K Eyerich, C Conrad, et al.
The British Journal of Dermatology|April 12, 2019
Continued treatment with secukinumab is associated with high retention or regain of responseM Augustin, D Thaci, K Eyerich, et al.
The British Journal of Dermatology|June 25, 2017
Sebum lipids influence macrophage polarization and activationM Lovászi, M Mattii, K Eyerich, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of the European Academy of Dermatology and Venereology : JEADV|February 20, 2024
IL-6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort studyA Reimer-Taschenbrecker, M Hess, M Davidovic, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 10, 2023
An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasisK Eyerich, J Krueger, M Stahle, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 19, 2016
Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donorN Garzorz, J Thomas, B Eberlein, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2020
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019T Luger, T Dirschka, K Eyerich, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 2, 2020
Transferability of suggested molecular classifiers for psoriasis and eczema to the Chinese populationM-N Xu, L Li, W Pan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 30, 2015
Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseasesN Garzorz, M Alsisi, A Todorova, et al.
The British Journal of Dermatology|November 10, 2019
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)D Thaçi, A Pinter, M Sebastian, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 7, 2023
Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2A Armstrong, K Eyerich, C Conrad, et al.
The British Journal of Dermatology|April 12, 2019
Continued treatment with secukinumab is associated with high retention or regain of responseM Augustin, D Thaci, K Eyerich, et al.
The British Journal of Dermatology|June 25, 2017
Sebum lipids influence macrophage polarization and activationM Lovászi, M Mattii, K Eyerich, et al.
Pageof 5